Monopar Therapeutics Inc [NASDAQ: MNPR] jumped around 28.03 points on Thursday, while shares priced at $32.66 at the close of the session, up 605.40%.
Compared to the average trading volume of 812.93K shares, MNPR reached a trading volume of 19489835 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Monopar Therapeutics Inc [MNPR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNPR shares is $26.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNPR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for Monopar Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 11, 2024. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on January 28, 2021, representing the official price target for Monopar Therapeutics Inc stock.
The Average True Range (ATR) for Monopar Therapeutics Inc is set at 2.94 The Price to Book ratio for the last quarter was 18.88, with the Price to Cash per share for the same quarter was set at 2.02.
How has MNPR stock performed recently?
Monopar Therapeutics Inc [MNPR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 471.98. With this latest performance, MNPR shares gained by 531.72% in over the last four-week period, additionally plugging by 940.96% over the last 6 months – not to mention a rise of 1299.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNPR stock in for the last two-week period is set at 93.57, with the RSI for the last a single of trading hit 95.31, and the three-weeks RSI is set at 91.95 for Monopar Therapeutics Inc [MNPR]. The present Moving Average for the last 50 days of trading for this stock 4.58, while it was recorded at 10.66 for the last single week of trading, and 3.63 for the last 200 days.
Monopar Therapeutics Inc [MNPR]: Deeper insight into the fundamentals
Monopar Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.59 and a Current Ratio set at 6.59.
Earnings analysis for Monopar Therapeutics Inc [MNPR]
With the latest financial reports released by the company, Monopar Therapeutics Inc posted -0.7/share EPS, while the average EPS was predicted by analysts to be reported at -0.85/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.15. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MNPR.
Insider trade positions for Monopar Therapeutics Inc [MNPR]
There are presently around $2.16%, or 4.62%% of MNPR stock, in the hands of institutional investors. The top three institutional holders of MNPR stocks are: MILLENNIUM MANAGEMENT LLC with ownership of 0.19 million shares, which is approximately 1.2159%. GEODE CAPITAL MANAGEMENT, LLC, holding 60036.0 shares of the stock with an approximate value of $$44906.0 in MNPR stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$34357.0 in MNPR stock with ownership which is approximately 0.2945%.
